A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
Clinical trial NCT03454620 · COMPLETED
Trial details
- NCT number
- NCT03454620
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-02
- Primary completion
- 2021-09-17
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.